<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034512438402</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034512438402</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Clinical</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Survivin</italic> SNP-carcinogen Interactions in Oral Cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Weng</surname><given-names>C.J.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512438402">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hsieh</surname><given-names>Y.H.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512438402">2</xref>
<xref ref-type="aff" rid="aff3-0022034512438402">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>M.K.</given-names></name>
<xref ref-type="aff" rid="aff4-0022034512438402">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tsai</surname><given-names>C.M.</given-names></name>
<xref ref-type="aff" rid="aff5-0022034512438402">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lin</surname><given-names>C.W.</given-names></name>
<xref ref-type="aff" rid="aff3-0022034512438402">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>S.F.</given-names></name>
<xref ref-type="aff" rid="aff6-0022034512438402">6</xref>
<xref ref-type="aff" rid="aff7-0022034512438402">7</xref>
<xref ref-type="corresp" rid="corresp1-0022034512438402">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034512438402"><label>1</label>Graduate Institute of Applied Science of Living, Tainan University of Technology, Yongkang District, Tainan City, Taiwan</aff>
<aff id="aff2-0022034512438402"><label>2</label>Department of Biochemistry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan</aff>
<aff id="aff3-0022034512438402"><label>3</label>Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung, Taiwan</aff>
<aff id="aff4-0022034512438402"><label>4</label>Department of Otorhinolaryngology-Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan</aff>
<aff id="aff5-0022034512438402"><label>5</label>Hualien Hospital, Department of Health, Executive Yuan, Hualien City, Hualien County, Taiwan</aff>
<aff id="aff6-0022034512438402"><label>6</label>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan</aff>
<aff id="aff7-0022034512438402"><label>7</label>Department of Medical Research, Chung Shan Medical University Hospital, 110, Section 1, Chien-Kuo N. Road, Taichung, 402, Taiwan</aff>
<author-notes>
<corresp id="corresp1-0022034512438402"><label>*</label><email>ysf@csmu.edu.tw</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>91</volume>
<issue>4</issue>
<fpage>358</fpage>
<lpage>363</lpage>
<history>
<date date-type="received">
<day>3</day>
<month>10</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>1</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>1</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>In Taiwan, oral cancer is causally associated with environmental carcinogens. <italic>Survivin</italic> is an anti-apoptotic protein and is generally considered a marker of malignancy. The current study explored the combined effect of <italic>survivin</italic> gene polymorphisms and environmental carcinogens on the risk and clinico-pathological development of oral cancer. Five single-nucleotide polymorphisms (SNPs) of <italic>survivin</italic> genes from 439 male patients with oral cancer and 424 male control participants (who did not have cancer) were analyzed. The <italic>survivin</italic> −31GG, +9194 GG, and +9809 TT homozygotes exhibited higher risk for oral cancer compared with the corresponding ancestral genotype, after adjustment for related confounders. The <italic>survivin</italic> −31, +9194, and +9809 SNPs combined with betel quid chewing and/or tobacco consumption could robustly elevate susceptibility to oral cancer. The distribution frequency of the −31 G: +9194 A: +9809 T haplotype was significantly higher in oral cancer patients than in control participants. These results suggest that <italic>survivin</italic> gene polymorphisms and their interactions with environmental carcinogens may increase susceptibility to oral cancer in Taiwanese men.</p>
<p><italic>Abbreviations</italic>: AOR, adjusted odds ratio; CI, confidence intervals; PCR, polymerase chain-reaction; SNP, single-nucleotide polymorphisms.</p>
</abstract>
<kwd-group>
<kwd>oral squamous cell carcinoma</kwd>
<kwd>single-nucleotide polymorphism</kwd>
<kwd><italic>Survivin</italic></kwd>
<kwd>environmental carcinogen</kwd>
<kwd>haplotype</kwd>
<kwd>betel quid</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034512438402" sec-type="intro">
<title>Introduction</title>
<p>Oral cancers can originate in any tissues of the mouth, but approximately 90% are squamous cell carcinomas (SCCs). Such cancers are known worldwide for their poor prognosis and major oncologic problems (<xref ref-type="bibr" rid="bibr8-0022034512438402">Jemal <italic>et al</italic>., 2008</xref>). The susceptibility of an individual to oral cancer is mediated by genetic factors and carcinogen-exposure behavior (<xref ref-type="bibr" rid="bibr9-0022034512438402">Lai and Lee, 2006</xref>; <xref ref-type="bibr" rid="bibr15-0022034512438402">Nagaraj <italic>et al</italic>., 2006</xref>). Among the genetic factors, single-nucleotide polymorphism (SNP) is the most common type of DNA sequence variation to influence the occurrence and progress of gene-related disease. Cancer is a gene-defect disease, and SNPs may possibly predict the risk of oral cancer (<xref ref-type="bibr" rid="bibr23-0022034512438402">Weng <italic>et al</italic>., 2011</xref>). Hence, the strategies of genotyping related SNPs and analyzing their distribution frequencies in a community are often used to predict the risk and prognosis of a cancer. Betel quid chewing, tobacco use, and alcohol consumption are 3 common carcinogen-exposure behaviors. The combination of these environmental carcinogens and certain gene polymorphisms might increase a person’s susceptibility to oral cancer (<xref ref-type="bibr" rid="bibr23-0022034512438402">Weng <italic>et al</italic>., 2011</xref>). Thus, SNPs in certain genes might affect one’s response to the stimulus toward carcinogenesis by environmental factors.</p>
<p><italic>Survivin</italic> (also called baculoviral IAP repeat-containing protein 5, “BIRC5”) is an anti-apoptotic protein. <italic>Survivin</italic> is typically undetectable in normal adult tissues but is over-expressed in various types of cancers (<xref ref-type="bibr" rid="bibr26-0022034512438402">L Yang <italic>et al</italic>., 2009</xref>). Prior research has reported that <italic>survivin</italic> is over-expressed in adenocarcinomas, such as gastric and colorectal cancers (<xref ref-type="bibr" rid="bibr4-0022034512438402">Gazouli <italic>et al</italic>., 2009</xref>). We speculated that it may also affect the risk of developing SCC such as oral cancer, or the outcome thereof. Several factors including genetic variation could cause unusual <italic>survivin</italic> expression and induce carcinogenesis by interfering in the functional domains of the <italic>survivin</italic> gene (<xref ref-type="bibr" rid="bibr3-0022034512438402">Duffy <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr17-0022034512438402">Shariat <italic>et al</italic>., 2007</xref>). The C/T, G/A, and C/G polymorphisms at −241 (rs17878467), −235 (rs17887126), and −31 (rs9904341) loci are located in the promoter region of the gene that reportedly may alter <italic>survivin</italic> expression. The non-synonymous A9194G SNP (rs2071214) and non-translated C9809T SNP (rs1042489) are found in exon4 and 3′-UTR, respectively, and might involve the expression or stability of <italic>survivin</italic> mRNA (<xref ref-type="bibr" rid="bibr6-0022034512438402">Hsieh <italic>et al</italic>., 2012</xref>).</p>
<p><italic>Survivin</italic> has been identified as a potential early predictor for tumor progression in oral mucosa (<xref ref-type="bibr" rid="bibr13-0022034512438402">Lo Muzio <italic>et al</italic>., 2003</xref>). However, the interactive effects between <italic>survivin</italic> SNPs and environmental carcinogens on susceptibility to and clinical features of oral cancer remain poorly investigated. Because of the specific epidemiology of oral cancer in Taiwan, fewer than 5% of cases occur among women. The present research constituted a case-control study to examine the interactions of <italic>survivin</italic> −241, −235, −31, +9194, and +9809 SNPs and environmental carcinogens, and their effects on the risk and clinicopathologic characteristics of oral cancer among men in Taiwan.</p>
</sec>
<sec id="section2-0022034512438402" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<sec id="section3-0022034512438402">
<title>Enrollment of Participants and Collection of Specimens</title>
<p>In total, 439 male patients with oral cancer were recruited as a case group at Chung Shan Medical University Hospital (Taichung, Taiwan) between 2008 and 2011. Control participants were enrolled at the same hospital after receiving physical examinations, with a final total of 424 men who had neither a self-reported history of cancer nor suspected cancer at any site. People with any other oral disease or pre-cancerous oral conditions were also excluded from the control group. All participants recruited for both groups were of the same race. Information on the participants’ exposure to carcinogens was obtained for both cases and controls from their completed questionnaires. Tumor differentiation was examined by a pathologist and rated according to the AJCC classification. Before the study commenced, approval was obtained from the Institutional Review Board of Chung Shan Medical University Hospital, and informed written consent was obtained from each participant.</p>
<p>At the start of the research, whole blood specimens were collected from both controls and oral cancer patients and were placed in tubes containing ethylenediaminetetraacetic acid (EDTA). The samples were then immediately centrifuged and stored at −80°C for further analysis.</p>
</sec>
<sec id="section4-0022034512438402">
<title>Genomic DNA Extraction</title>
<p>Genomic DNA was extracted from the blood samples by means of QIAamp DNA blood mini-kits (Qiagen, Valencia, CA, USA), according to the manufacturer’s instructions. The DNA was dissolved in TE buffer [10 mM Tris (pH 7.8), 1 mM EDTA] and then quantified by a measurement of OD260. The final preparation was stored at −20°C and used as templates for polymerase chain-reaction (PCR).</p>
</sec>
<sec id="section5-0022034512438402">
<title>Real-time PCR</title>
<p>The allelic discrimination of the <italic>survivin</italic> −241 (rs17878467), <italic>survivin</italic> −235 (rs17887126), <italic>survivin</italic> −31 (rs9904341), <italic>survivin</italic> +9194 (rs2071214), and <italic>survivin</italic> +9809 (rs1042489) allelic polymorphisms was assessed with the ABI StepOne™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The results were analyzed with SDS v3.0 software (Applied Biosystems) with the TaqMan assay.</p>
</sec>
<sec id="section6-0022034512438402">
<title>Statistical Analysis</title>
<p>The Hardy-Weinberg equilibrium was assessed by a goodness-of-fit chi-squared test for bi-allelic markers. The Mann-Whitney U-test and Fisher’s exact test were used to compare the distributions of demographic characteristics between controls and oral cancer cases. The adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were estimated for the association between genotype frequencies and oral cancer risk, as well as clinico-pathological characteristics. To calculate these estimates, we used multiple logistic regression models after controlling for age, betel quid chewing, alcohol consumption, and tobacco use. The interactions of survivin genetic polymorphisms (rs9904341, rs2071214 and rs10422489) and each demographic characteristic (smoking status, alcohol drinking status and betel quid chewing status) individually, with adjusting for other covariates (age) were also evaluated. To test these interactions, we fitted a logistic regression model with main effects (survivin genetic polymorphism, smoking status, alcohol drinking status and betel quid chewing status), as well as an interaction term between them (survivin genotypes*demographic characteristic), comparing the model against a model with only the main effects. Interaction effect was defined as the difference of their deviance, and further assessed by the likelihood ratio test to calculate χ<sup>2</sup> and <italic>P</italic> values (<xref ref-type="bibr" rid="bibr16-0022034512438402">Schlesselman, 1982</xref>). A <italic>P-</italic>value less than 0.05 was considered statistically significant. Data were analyzed with SAS statistical software (Version 9.1, 2005; SAS Institute Inc., Cary, NC, USA).</p>
</sec>
</sec>
<sec id="section7-0022034512438402" sec-type="results">
<title>Results</title>
<p>The demographic characteristics of our recruited specimens are shown in Appendix Table 1. We found significant differences between the control and oral cancer groups for the distributions of age, betel quid chewing, alcohol consumption, and tobacco use. Hence, we calculated AORs (with 95% CI) by multiple logistic regression models after controlling for the related covariates in each comparison to reduce the possible interference of the confounders.</p>
<table-wrap id="table1-0022034512438402" position="float">
<label>Table 1.</label>
<caption>
<p>Distribution Frequency of <italic>Survivin</italic> Genotypes in 424 Control Individuals and 439 Patients with Oral Cancer</p>
</caption>
<graphic alternate-form-of="table1-0022034512438402" xlink:href="10.1177_0022034512438402-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="center">Controls (N = 424) n (%)</th>
<th align="center">Patients (N = 439) n (%)</th>
<th align="center">OR (95% CI)</th>
<th align="center">AOR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5"><bold>−241</bold></td>
</tr>
<tr>
<td>CC</td>
<td>424 (100)</td>
<td>439 (100)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CT</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td>TT</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td colspan="5"><bold>−235</bold></td>
</tr>
<tr>
<td>GG</td>
<td>424 (100)</td>
<td>439 (100)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>GA</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td>AA</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td colspan="5"><bold>−31</bold></td>
</tr>
<tr>
<td>CC</td>
<td>126 (29.7)</td>
<td>102 (23.2)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CG</td>
<td>204 (48.1)</td>
<td>218 (49.7)</td>
<td>1.3 (0.9-1.8)</td>
<td>1.3 (0.8-2.2)</td>
</tr>
<tr>
<td>GG</td>
<td>94 (22.2)</td>
<td>119 (27.1)</td>
<td>1.5 (1.0-2.2)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
<td>1.7 (1.0-3.1)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
</tr>
<tr>
<td>CG+GG</td>
<td>298 (70.3)</td>
<td>337 (76.8)</td>
<td>1.3 (1.0-1.8)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
<td>1.4 (0.9-2.2)</td>
</tr>
<tr>
<td colspan="5"><bold>+9194</bold></td>
</tr>
<tr>
<td>AA</td>
<td>304 (71.7)</td>
<td>285 (64.9)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>AG</td>
<td>114 (26.9)</td>
<td>137 (31.2)</td>
<td>1.2 (0.9-1.7)</td>
<td>1.1 (0.7-1.7)</td>
</tr>
<tr>
<td>GG</td>
<td>6 (1.4)</td>
<td>17 (3.9)</td>
<td>3.0 (1.1-7.7)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
<td>4.5 (1.1-17.5)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
</tr>
<tr>
<td>AG+GG</td>
<td>120 (28.3)</td>
<td>154 (35.1)</td>
<td>1.3 (1.0-1.8)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
<td>1.2 (0.8-1.8)</td>
</tr>
<tr>
<td colspan="5"><bold>+9809</bold></td>
</tr>
<tr>
<td>CC</td>
<td>107 (25.2)</td>
<td>79 (18.0)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CT</td>
<td>208 (49.1)</td>
<td>204 (46.5)</td>
<td>1.3 (0.9-1.8)</td>
<td>1.3 (0.8-2.2)</td>
</tr>
<tr>
<td>TT</td>
<td>109 (25.7)</td>
<td>156 (35.5)</td>
<td>1.9 (1.3-2.8)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
<td>2.8 (1.5-4.9)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
</tr>
<tr>
<td>CT+TT</td>
<td>317 (74.8)</td>
<td>360 (82.0)</td>
<td>1.5 (1.1-2.1)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
<td>1.7 (1.1-2.7)<xref ref-type="table-fn" rid="table-fn3-0022034512438402">*</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0022034512438402">
<p>The odds ratios (ORs) with their 95% confidence intervals (CIs) were estimated by logistic regression models.</p>
</fn>
<fn id="table-fn2-0022034512438402">
<p>The adjusted odds ratios (AORs) with their 95% CIs were estimated by multiple logistic regression models after adjustment for age, betel quid chewing, alcohol consumption, and tobacco use.</p>
</fn>
<fn id="table-fn3-0022034512438402">
<label>*</label>
<p>p value &lt; 0.05 as statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>All analyzed gene markers in our control group were statistically verified as being in the Hardy-Weinberg equilibrium (<italic>P</italic> &gt; 0.05). Analysis of the statistical data shown in <xref ref-type="table" rid="table1-0022034512438402">Table 1</xref> indicates that −241 C/C, −235 G/G, −31 C/G, +9194 A/A, and +9809 C/T had the highest distribution frequency of the <italic>survivin</italic> genotypes; apart from −241 and −235, the same <italic>survivin</italic> SNPs were observed in both oral cancer patients and controls. The −31 G/G, +9194 GG, and +9809 TT homozygotes exhibited significant high risks for oral cancer, at 1.7-fold, 4.5-fold, and 2.8-fold, respectively, compared with the corresponding ancestral genotypes (after adjustment for related confounders). For participants with any of the polymorphic alleles at a site, only +9809 presented a significant high risk for oral cancer (AOR = 1.7; 95% CI: 1.1-2.7) compared with the ancestral genotype. The non-polymorphic characteristics of <italic>survivin</italic> −241 and −235 have been confirmed by comparison of the results from a commercial positive control and sequencing of the primers. In addition, a polymorphic genotype had been noted in a patient with hepatocellular carcinoma when the same primers were used (<xref ref-type="bibr" rid="bibr6-0022034512438402">Hsieh <italic>et al</italic>., 2012</xref>). We thus presumed that the lack of <italic>survivin</italic> −241 and −235 polymorphisms might be a genetic characteristic of Taiwanese or Asian people, but further research is required to confirm this hypothesis. In the current study, we were obliged to exclude <italic>survivin</italic> −241 and −235 from subsequent analysis.</p>
<p>Several pair interactions showed a significant elevation for risk of oral cancer (Appendix Table 2). The pairs were smoking and betel quid consumption (χ<sup>2</sup>= 295.24, 1 df, p &lt; 0.0001), smoking and alcohol consumption (χ<sup>2</sup>= 16.37, 1 df, p &lt; 0.0001), and betel quid chewing and alcohol consumption (χ<sup>2</sup>= 119.58, 1 df, p &lt; 0.0001). We then analyzed the interaction between each allelic polymorphism and a single carcinogen by controlling the other carcinogens. Among the 582 smokers (in both groups), susceptibility to oral cancer associated with <italic>suvivin</italic> −31, +9194, or the +9809 polymorphic allele combined with betel quid chewing was dramatically elevated to 33.3-fold, 26.3-fold, and 37.8-fold, respectively, compared with the corresponding ancestral genotype without betel quid chewing (<xref ref-type="table" rid="table2-0022034512438402">Table 2</xref>). A similar combined effect between polymorphisms and betel quid chewing was found for the 281 non-smokers (Appendix Table 3). Among the 435 betel quid consumers (in both groups), a combination of the 3 SNPs with smoking increased the risk of oral cancer as follows: +9194 and +9809 polymorphic alleles were associated with a significantly increased risk (p &lt; 0.05), but −31 polymorphic allele was not (p &gt; 0.05) (<xref ref-type="table" rid="table3-0022034512438402">Table 3</xref>). A similar combined effect was observed among the 428 participants who did not consume betel quid (Appendix Table 4). Alcohol consumption did not show a combined effect with any polymorphic allele of <italic>survivin</italic> −31, +9194, or +9809 after adjustment for related covariates (Appendix Table 5). We thus excluded the variable of alcohol consumption and focused on betel quid chewing and tobacco use when further assessing the risk of oral cancer associated with different <italic>survivin</italic> genotypes.</p>
<table-wrap id="table2-0022034512438402" position="float">
<label>Table 2.</label>
<caption>
<p>Adjusted Odds Ratio (AOR) and 95% Confidence Interval (CI) of Oral Cancer Associated with Survivin Genotypic Frequencies and Betel Quid Chewing among 582 Smokers</p>
</caption>
<graphic alternate-form-of="table2-0022034512438402" xlink:href="10.1177_0022034512438402-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="center">Controls (N = 202) n (%)</th>
<th align="center">Patients (N = 380) n (%)</th>
<th align="center">OR (95% CI)</th>
<th align="center">AOR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5"><italic>Survivin</italic> −31</td>
</tr>
<tr>
<td>CC genotype without betel quid chewing</td>
<td>31 (15.3)</td>
<td>13 (3.4)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CG/GG genotype without betel quid chewing</td>
<td>101 (50.0)</td>
<td>45 (11.8)</td>
<td>1.0 (0.5-2.2)</td>
<td>1.3 (0.4-3.9)</td>
</tr>
<tr>
<td>CC genotype with betel quid chewing</td>
<td>20 (9.9)</td>
<td>76 (20.1)</td>
<td>9.0 (4.0-20.4)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
<td>31.5 (6.0-164.1)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>CG/GG genotype with betel quid chewing</td>
<td>50 (24.8)</td>
<td>246 (64.7)</td>
<td>11.7 (5.7-23.9)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
<td>33.3 (9.3-118.8)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>Test for interaction</td>
<td colspan="4">χ<sup>2</sup> = 55.98 (1 df), p &lt; 0.0001</td>
</tr>
<tr>
<td colspan="5"><italic>Survivin</italic> +9194</td>
</tr>
<tr>
<td>AA genotype without betel quid chewing</td>
<td>93 (46.0)</td>
<td>40 (10.5)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>AG/GG genotype without betel quid chewing</td>
<td>39 (19.3)</td>
<td>18 (4.7)</td>
<td>1.0 (0.5-2.0)</td>
<td>1.6 (0.6-4.2)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>AA genotype with betel quid chewing</td>
<td>49 (24.3)</td>
<td>206 (54.2)</td>
<td>9.7 (6.0-15.8)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
<td>14.4 (7.6-27.4)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>AG/GG genotype with betel quid chewing</td>
<td>21 (10.4)</td>
<td>116 (30.5)</td>
<td>12.8 (7.0-23.2)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
<td>26.3 (10.9-63.5)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>Test for interaction</td>
<td colspan="4">χ<sup>2</sup> = 91.76 (1 df), p &lt; 0.0001</td>
</tr>
<tr>
<td colspan="5"><italic>Survivin</italic> +9809</td>
</tr>
<tr>
<td>CC genotype without betel quid chewing</td>
<td>36 (17.8)</td>
<td>10 (2.6)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CT/TT genotype without betel quid chewing</td>
<td>96 (47.5)</td>
<td>48 (12.6)</td>
<td>1.8 (0.8-3.9)</td>
<td>1.8 (0.6-5.2)</td>
</tr>
<tr>
<td>CC genotype with betel quid chewing</td>
<td>20 (9.9)</td>
<td>57 (15.1)</td>
<td>10.2 (4.3-24.3)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
<td>13.0 (3.6-46.4)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>CT/TT genotype with betel quid chewing</td>
<td>50 (24.8)</td>
<td>265 (69.7)</td>
<td>19.0 (8.8-40.9)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
<td>37.8 (12.7-112.6)<xref ref-type="table-fn" rid="table-fn6-0022034512438402">*</xref></td>
</tr>
<tr>
<td>Test for interaction</td>
<td colspan="4">χ<sup>2</sup> = 73.56 (1 df), p &lt; 0.0001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0022034512438402">
<p>The ORs with their 95% CIs were estimated by logistic regression models.</p>
</fn>
<fn id="table-fn5-0022034512438402">
<p>The AORs with their 95% CIs were estimated by multiple logistic regression models after adjustment for age and alcohol consumption.</p>
</fn>
<fn id="table-fn6-0022034512438402">
<label>*</label>
<p>p value &lt; 0.05 as statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0022034512438402" position="float">
<label>Table 3.</label>
<caption>
<p>Adjusted Odds Ratio (AOR) and 95% Confidence Interval (CI) of Oral Cancer Associated with Survivin Genotypic Frequencies and Smoking among 435 Betel Quid Consumers</p>
</caption>
<graphic alternate-form-of="table3-0022034512438402" xlink:href="10.1177_0022034512438402-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="center">Controls (N = 90) n (%)</th>
<th align="center">Patients (N = 345) n (%)</th>
<th align="center">OR (95% CI)</th>
<th align="center">AOR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5"><italic>Survivin</italic> −31</td>
</tr>
<tr>
<td>CC genotype without smoking</td>
<td>4 (4.4)</td>
<td>5 (1.4)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CG/GG genotype without smoking</td>
<td>16 (17.8)</td>
<td>18 (5.2)</td>
<td>0.9 (0.2-3.9)</td>
<td>1.1 (0.2-5.7)</td>
</tr>
<tr>
<td>CC genotype with smoking</td>
<td>20 (22.2)</td>
<td>76 (22.1)</td>
<td>3.0 (0.7-12.3)</td>
<td>1.8 (0.2-16.6)</td>
</tr>
<tr>
<td>CG/GG genotype with smoking</td>
<td>50 (55.6)</td>
<td>246 (71.3)</td>
<td>3.9 (1.0-15.1)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
<td>5.5 (0.4-63.9)</td>
</tr>
<tr>
<td>Test for interaction</td>
<td colspan="4">χ<sup>2</sup> = 2.59 (1 df), p = 0.11</td>
</tr>
<tr>
<td colspan="5"><italic>Survivin</italic> +9194</td>
</tr>
<tr>
<td>AA genotype without smoking</td>
<td>16 (17.8)</td>
<td>16 (4.6)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>AG/GG genotype without smoking</td>
<td>4 (4.4)</td>
<td>7 (2.1)</td>
<td>1.7 (0.4-7.1)</td>
<td>3.7 (0.1-98.4)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
</tr>
<tr>
<td>AA genotype with smoking</td>
<td>49 (54.4)</td>
<td>206 (59.7)</td>
<td>4.2 (1.9-8.9)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
<td>5.8 (2.1-16.4)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
</tr>
<tr>
<td>AG/GG genotype with smoking</td>
<td>21 (23.3)</td>
<td>116 (33.6)</td>
<td>5.5 (2.3-12.7)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
<td>9.4 (2.5-35.0)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
</tr>
<tr>
<td>Test for interaction</td>
<td colspan="4">χ<sup>2</sup> = 11.87 (1 df), p = 0.0005</td>
</tr>
<tr>
<td colspan="5"><italic>Survivin</italic> +9809</td>
</tr>
<tr>
<td>CC genotype without smoking</td>
<td>9 (10.0)</td>
<td>6 (1.7)</td>
<td>1.0</td>
<td>1.0</td>
</tr>
<tr>
<td>CT/TT genotype without smoking</td>
<td>11 (12.2)</td>
<td>17 (4.9)</td>
<td>2.3 (0.6-8.3)</td>
<td>0.9 (0.0-42.1)</td>
</tr>
<tr>
<td>CC genotype with smoking</td>
<td>20 (22.2)</td>
<td>57 (16.5)</td>
<td>4.2 (1.3-13.5)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
<td>6.7 (0.7-60.3)</td>
</tr>
<tr>
<td>CT/TT genotype with smoking</td>
<td>50 (55.6)</td>
<td>265 (76.8)</td>
<td>7.9 (2.7-23.3)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
<td>14.6 (2.7-77.7)<xref ref-type="table-fn" rid="table-fn9-0022034512438402">*</xref></td>
</tr>
<tr>
<td>Test for interaction</td>
<td colspan="4">χ<sup>2</sup> = 9.17 (1 df), p = 0.0025</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0022034512438402">
<p>The ORs with their 95% CIs were estimated by logistic regression models.</p>
</fn>
<fn id="table-fn8-0022034512438402">
<p>The AORs with their 95% CIs were estimated by multiple logistic regression models after adjustment for age and alcohol consumption.</p>
</fn>
<fn id="table-fn9-0022034512438402">
<label>*</label>
<p>p value &lt; 0.05 as statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Subsequently, Haploview software and PHASE program were used to calculate LD and reconstruct the common haplotypes, respectively. We found that rs9904341, rs2071214, and rs10422489 showed a high degree of D′ in our study (Appendix Fig.). The haplotype distributions of <italic>suvivin</italic> −31, +9194, and +9809 showed that 2 minor haplotypes, CAC and GAT, significantly (<italic>P</italic> &lt; 0.001) changed the risk for oral cancer 0.5-fold and 1.4-fold, respectively, compared with the reference GAC haplotype (<xref ref-type="table" rid="table4-0022034512438402">Table 4</xref>).</p>
<table-wrap id="table4-0022034512438402" position="float">
<label>Table 4.</label>
<caption>
<p>Distribution Frequency of Survivin Haplotype in Control Individuals and Patients with Oral Cancer</p>
</caption>
<graphic alternate-form-of="table4-0022034512438402" xlink:href="10.1177_0022034512438402-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="3">Variable</th>
<th/>
<th/>
<th/>
<th/>
</tr>
<tr>
<th align="center">−31 C/G</th>
<th align="center">+9194 A/G</th>
<th align="center">+9809 C/T</th>
<th align="center">Controls (N = 848) n (%)</th>
<th align="center">Patients (N = 878) n (%)</th>
<th align="center">OR (95% CI)</th>
<th align="center">p value</th>
</tr>
</thead>
<tbody>
<tr>
<td>G</td>
<td>A</td>
<td>C</td>
<td>263 (31.0)</td>
<td>268 (30.5)</td>
<td>Reference</td>
<td/>
</tr>
<tr>
<td>C</td>
<td>A</td>
<td>T</td>
<td>172 (20.3)</td>
<td>159 (18.1)</td>
<td>0.9 (0.6-1.1)</td>
<td>0.487</td>
</tr>
<tr>
<td>C</td>
<td>A</td>
<td>C</td>
<td>159 (18.8)</td>
<td>92 (10.5)</td>
<td>0.5 (0.4-0.7)<xref ref-type="table-fn" rid="table-fn10-0022034512438402">*</xref></td>
<td>&lt; 0.001</td>
</tr>
<tr>
<td>G</td>
<td>A</td>
<td>T</td>
<td>128 (15.1)</td>
<td>188 (21.5)</td>
<td>1.4 (1.0-1.9)<xref ref-type="table-fn" rid="table-fn10-0022034512438402">*</xref></td>
<td>&lt;0.011</td>
</tr>
<tr>
<td>C</td>
<td>G</td>
<td>T</td>
<td>125 (14.7)</td>
<td>169 (19.2)</td>
<td>1.3 (0.9-1.7)</td>
<td>0.053</td>
</tr>
<tr>
<td>G</td>
<td>G</td>
<td>T</td>
<td>1 (0.1)</td>
<td>1 (0.1)</td>
<td>0.9 (0.0-15.7)</td>
<td>0.989</td>
</tr>
<tr>
<td>C</td>
<td>G</td>
<td>C</td>
<td>0 (0)</td>
<td>1 (0.1)</td>
<td align="center">-</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-0022034512438402">
<label>*</label>
<p>p value &lt; 0.05 as statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-0022034512438402" sec-type="discussion">
<title>Discussion</title>
<p>Compared with the control group, a higher proportion of oral cancer patients used betel quid, tobacco, or alcohol (Appendix Table 1). This finding suggested that these 3 environmental carcinogens may be associated with risk for oral cancer. Betel quid and tobacco consumption appeared to be particularly strongly associated with oral cancer, a finding that is congruent with prior research (<xref ref-type="bibr" rid="bibr28-0022034512438402">Yen <italic>et al</italic>., 2008</xref>). Betel quid chewing has been found to stimulate the protein level of matrix metalloproteinase (MMP)-9 in the saliva of healthy people (<xref ref-type="bibr" rid="bibr12-0022034512438402">Liu <italic>et al</italic>., 2005</xref>). Lime-Piper betel quid may also increase the protein levels of c-fos and c-jun proto-oncogenes (<xref ref-type="bibr" rid="bibr10-0022034512438402">Lin <italic>et al</italic>., 2004</xref>). Consumption of tobacco may significantly induce the expression of nuclear hypoxia-inducible factor (HIF)-1α, which is an unfavorable prognostic factor in oral cancer (<xref ref-type="bibr" rid="bibr11-0022034512438402">Lin <italic>et al</italic>., 2008</xref>). These lines of evidence suggest that environmental carcinogen exposure is involved in the formation or pathogenesis of oral cancer.</p>
<p><italic>Survivin</italic> plays an anti-apoptotic role and causes tumor cells to evade apoptosis (<xref ref-type="bibr" rid="bibr1-0022034512438402">Ambrosini <italic>et al</italic>., 1998</xref>). Hence, abnormally high levels of <italic>survivin</italic> might cause uncontrollable cell division and result in tumorigenesis. The −31 C/G, −235 G/A, and −241 C/T SNPs are known to be associated with the modulation of <italic>survivin</italic> expression (<xref ref-type="bibr" rid="bibr25-0022034512438402">Xu <italic>et al</italic>., 2004</xref>). Previous research has shown that <italic>survivin −</italic>31 C/G SNP is positively correlated with the risk of developing gastric and colorectal cancers (<xref ref-type="bibr" rid="bibr4-0022034512438402">Gazouli <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr27-0022034512438402">X Yang <italic>et al</italic>., 2009</xref>), but has no significant effect on esophageal squamous cell and breast carcinomas (<xref ref-type="bibr" rid="bibr2-0022034512438402">Boidot <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr27-0022034512438402">X Yang <italic>et al</italic>., 2009</xref>). A meta-analysis suggested that <italic>survivin</italic> −31 C/G SNP plays an important role in cancer risk, especially in the Asian population (<xref ref-type="bibr" rid="bibr18-0022034512438402">Srivastava <italic>et al</italic>., 2012</xref>). A separate study examined the role of <italic>survivin</italic> −31 C/G SNP in susceptibility to and survival of esophageal cancer among the northern Indian population (<xref ref-type="bibr" rid="bibr22-0022034512438402">Upadhyay <italic>et al</italic>., 2010</xref>).</p>
<p>The present study revealed that <italic>survivin</italic> −31 GG was significantly associated with risk for oral cancer among Taiwanese men, but CG was not (<xref ref-type="table" rid="table1-0022034512438402">Table 1</xref>). We thus presumed that the genetic polymorphism in the <italic>survivin</italic> −31 locus might be a cancer-type-dependent and race-dependent factor for predicting the risk of cancer. Prior research found that the <italic>survivin</italic> −241 C/T SNP exhibited a normal genotype frequency distribution among 168 ovarian cancer patients (<xref ref-type="bibr" rid="bibr5-0022034512438402">Han <italic>et al</italic>., 2009</xref>). In our recruited Taiwanese population, neither −235 G/A nor −241 C/T SNP of <italic>survivin</italic> was found (<xref ref-type="table" rid="table1-0022034512438402">Table 1</xref>). Furthermore, a Korean study found a strong LD between the <italic>survivin</italic> −31 and +9194, but not + 9809, polymorphisms (<xref ref-type="bibr" rid="bibr7-0022034512438402">Jang <italic>et al</italic>., 2008</xref>). However, we found that <italic>survivin</italic> −31, +9194, and <italic>survivin</italic> +9809 showed a high degree of D′ in our study. The role of these genetic polymorphisms in the development of cancer among different racial groups requires further investigation.</p>
<p><xref ref-type="bibr" rid="bibr19-0022034512438402">Su <italic>et al</italic>. (2010)</xref> demonstrated that oral cancer patients with a high expression of <italic>survivin</italic> might have lower 5-year survival rates than patients with low <italic>survivin</italic> expression. The +9194 polymorphism, located at exon4 of the <italic>survivin</italic> gene, may enhance the bioactivity or expression of <italic>survivin</italic>. Whereas +9809 polymorphism is located at the 3′-UTR of the <italic>survivin</italic> gene, regulatory events such as mRNA stability and post-transcriptional modification might occur through binding of microRNAs (<xref ref-type="bibr" rid="bibr14-0022034512438402">Majoros and Ohler, 2007</xref>). These hypotheses provide possible explanations for the association between +9194 and +9809 polymorphisms and the high risk of oral cancer (<xref ref-type="table" rid="table1-0022034512438402">Table 1</xref>).</p>
<p>Previous research has indicated that reactive oxygen species may be generated in alkaline saliva, which could result from a combination of the chewing of betel quid and cigarette-related nicotine-induced DNA damage (<xref ref-type="bibr" rid="bibr24-0022034512438402">Wu <italic>et al</italic>., 2005</xref>). Hydroxychavicol (a phenolic component in betel leaf) is able to modulate cigarette carcinogen benzo[a]pyrene-mediated toxic effects by inducing dihydrodiol dehydrogenase (<xref ref-type="bibr" rid="bibr20-0022034512438402">Tang <italic>et al</italic>., 2004</xref>). This evidence suggests a possible molecular explanation for the interactive effect of betel quid chewing and cigarette smoking on the risk of oral cancer (Appendix Table 2). The genomic changes progressively alter the cellular phenotype, which may lead the cells to evolve from a pre-neoplastic stage into cancer (<xref ref-type="bibr" rid="bibr21-0022034512438402">Thorgeirsson and Grisham, 2002</xref>). Several gene polymorphisms combined with environmental carcinogens (such as betel quid or tobacco use) have been found to increase susceptibility to oral cancer (<xref ref-type="bibr" rid="bibr23-0022034512438402">Weng <italic>et al</italic>., 2011</xref>). Clearly, the interaction between genes and environmental carcinogens may play a pivotal role in carcinogenesis.</p>
<p>We further analyzed the association between SNPs and the clinical status of oral cancer cases. The results showed that <italic>survivin</italic> −31 and +9809 polymorphic alleles were not associated with any of the tested clinical or pathological parameters (Appendix Table 6). However, oral cancer patients carrying the <italic>survivin +</italic>9194 polymorphic allele showed significantly greater tumor size than patients carrying ancestral genotypes, when combined with betel quid chewing (Appendix Table 7). The combined effect of <italic>survivin</italic> SNPs and carcinogens on the clinicopathological development of oral cancer should be verified by future research. Ideally, future studies should include a greater number of cases and should consider more oral cancer risk factors during analysis. Additionally, cloning of the target gene to transform it into a host cell, and then performing a xenograft <italic>in vivo</italic>, might provide another practical strategy for further research.</p>
<p>In conclusion, we found <italic>survivin</italic> −31, +9194, and +9809 SNPs to be correlated with susceptibility to oral cancer. Interactions among these 3 SNPs and exposure to environmental carcinogens in the form of betel quid or tobacco may significantly increase the risk of oral cancer. Further research is necessary to verify the combined effect of <italic>survivin</italic> SNPs and carcinogens on the clinico-pathological development of oral cancer.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supported-by">
<p>This study was partially supported by the <grant-sponsor>National Science Council</grant-sponsor>, <grant-num>NSC98-2313-B-165-001</grant-num>, Taiwan, Republic of China.</p>
</fn>
<fn fn-type="conflict">
<p>The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="supplementary-material">
<p>A supplemental appendix to this article is published electronically only at <ext-link ext-link-type="uri" xlink:href="http://jdr.sagepub.com/supplemental">http://jdr.sagepub.com/supplemental</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ambrosini</surname><given-names>G</given-names></name>
<name><surname>Adida</surname><given-names>C</given-names></name>
<name><surname>Sirugo</surname><given-names>G</given-names></name>
<name><surname>Altieri</surname><given-names>DC</given-names></name>
</person-group> (<year>1998</year>). <article-title>Induction of apoptosis and inhibition of cell proliferation by BIRC5 gene targeting</article-title>. <source>J Biol Chem</source> <volume>273</volume>:<fpage>11177</fpage>-<lpage>11182</lpage>.</citation>
</ref>
<ref id="bibr2-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boidot</surname><given-names>R</given-names></name>
<name><surname>Vegran</surname><given-names>F</given-names></name>
<name><surname>Jacob</surname><given-names>D</given-names></name>
<name><surname>Chevrier</surname><given-names>S</given-names></name>
<name><surname>Gangneux</surname><given-names>N</given-names></name>
<name><surname>Taboureau</surname><given-names>J</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas</article-title>. <source>Genes Chromosomes Cancer</source> <volume>47</volume>:<fpage>299</fpage>-<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr3-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duffy</surname><given-names>MJ</given-names></name>
<name><surname>O’Donovan</surname><given-names>N</given-names></name>
<name><surname>Brennan</surname><given-names>DJ</given-names></name>
<name><surname>Gallagher</surname><given-names>WM</given-names></name>
<name><surname>Ryan</surname><given-names>BM</given-names></name>
</person-group> (<year>2007</year>). <article-title>Survivin: a promising tumor biomarker</article-title>. <source>Cancer Lett</source> <volume>249</volume>:<fpage>49</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr4-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gazouli</surname><given-names>M</given-names></name>
<name><surname>Tzanakis</surname><given-names>N</given-names></name>
<name><surname>Rallis</surname><given-names>G</given-names></name>
<name><surname>Theodoropoulos</surname><given-names>G</given-names></name>
<name><surname>Papaconstantinou</surname><given-names>I</given-names></name>
<name><surname>Kostakis</surname><given-names>A</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Survivin −31G/C promoter polymorphism and sporadic colorectal cancer</article-title>. <source>Int J Colorectal Dis</source> <volume>24</volume>:<fpage>145</fpage>-<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr5-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Han</surname><given-names>CH</given-names></name>
<name><surname>Wei</surname><given-names>Q</given-names></name>
<name><surname>Lu</surname><given-names>KK</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Mills</surname><given-names>GB</given-names></name>
<name><surname>Wang</surname><given-names>LE</given-names></name>
</person-group> (<year>2009</year>). <article-title>Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer</article-title>. <source>Int J Clin Exp Med</source> <volume>2</volume>:<fpage>289</fpage>-<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr6-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsieh</surname><given-names>YS</given-names></name>
<name><surname>Tsai</surname><given-names>CM</given-names></name>
<name><surname>Yeh</surname><given-names>CB</given-names></name>
<name><surname>Yang</surname><given-names>SF</given-names></name>
<name><surname>Hsieh</surname><given-names>YH</given-names></name>
<name><surname>Weng</surname><given-names>CJ</given-names></name>
</person-group> (<year>2012</year>). <article-title><italic>Survivin</italic> T9809C, an SNP located in 3′-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma</article-title>. <source>Ann Surg Oncol</source> (<year>in press</year>).</citation>
</ref>
<ref id="bibr7-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jang</surname><given-names>JS</given-names></name>
<name><surname>Kim</surname><given-names>KM</given-names></name>
<name><surname>Kang</surname><given-names>KH</given-names></name>
<name><surname>Choi</surname><given-names>JE</given-names></name>
<name><surname>Lee</surname><given-names>WK</given-names></name>
<name><surname>Kim</surname><given-names>CH</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Polymorphisms in the survivin gene and the risk of lung cancer</article-title>. <source>Lung Cancer</source> <volume>60</volume>:<fpage>31</fpage>-<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr8-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jemal</surname><given-names>A</given-names></name>
<name><surname>Siegel</surname><given-names>R</given-names></name>
<name><surname>Ward</surname><given-names>E</given-names></name>
<name><surname>Hao</surname><given-names>Y</given-names></name>
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Murray</surname><given-names>T</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Cancer statistics, 2008</article-title>. <source>CA Cancer J Clin</source> <volume>58</volume>:<fpage>71</fpage>-<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr9-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lai</surname><given-names>KC</given-names></name>
<name><surname>Lee</surname><given-names>TC</given-names></name>
</person-group> (<year>2006</year>). <article-title>Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts</article-title>. <source>Mutat Res</source> <volume>599</volume>:<fpage>66</fpage>-<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr10-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>MH</given-names></name>
<name><surname>Wang</surname><given-names>CJ</given-names></name>
<name><surname>Huang</surname><given-names>HP</given-names></name>
<name><surname>Chou</surname><given-names>MY</given-names></name>
<name><surname>Chou</surname><given-names>FP</given-names></name>
</person-group> (<year>2004</year>). <article-title>The tumorigenic characteristics of lime-piper betel quid-transformed JB6 cells</article-title>. <source>Arch Toxicol</source> <volume>78</volume>:<fpage>167</fpage>-<lpage>173</lpage>.</citation>
</ref>
<ref id="bibr11-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>PY</given-names></name>
<name><surname>Yu</surname><given-names>CH</given-names></name>
<name><surname>Wang</surname><given-names>JT</given-names></name>
<name><surname>Chen</surname><given-names>HH</given-names></name>
<name><surname>Cheng</surname><given-names>SJ</given-names></name>
<name><surname>Kuo</surname><given-names>MY</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan</article-title>. <source>J Oral Pathol Med</source> <volume>37</volume>:<fpage>18</fpage>-<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr12-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>SY</given-names></name>
<name><surname>Lin</surname><given-names>MH</given-names></name>
<name><surname>Yang</surname><given-names>SC</given-names></name>
<name><surname>Huang</surname><given-names>GC</given-names></name>
<name><surname>Chang</surname><given-names>L</given-names></name>
<name><surname>Chang</surname><given-names>S</given-names></name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9</article-title>. <source>J Formos Med Assoc</source> <volume>104</volume>:<fpage>113</fpage>-<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr13-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lo Muzio</surname><given-names>L</given-names></name>
<name><surname>Pannone</surname><given-names>G</given-names></name>
<name><surname>Leonardi</surname><given-names>R</given-names></name>
<name><surname>Staibano</surname><given-names>S</given-names></name>
<name><surname>Mignogna</surname><given-names>MD</given-names></name>
<name><surname>De Rosa</surname><given-names>G</given-names></name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Survivin, a potential early predictor of tumor progression in the oral mucosa</article-title>. <source>J Dent Res</source> <volume>82</volume>:<fpage>923</fpage>-<lpage>928</lpage>.</citation>
</ref>
<ref id="bibr14-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Majoros</surname><given-names>WH</given-names></name>
<name><surname>Ohler</surname><given-names>U</given-names></name>
</person-group> (<year>2007</year>). <article-title>Spatial preferences of microRNA targets in 3′ untranslated regions</article-title>. <source>BMC Genomics</source> <volume>8</volume>:<fpage>152</fpage>.</citation>
</ref>
<ref id="bibr15-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nagaraj</surname><given-names>NS</given-names></name>
<name><surname>Beckers</surname><given-names>S</given-names></name>
<name><surname>Mensah</surname><given-names>JK</given-names></name>
<name><surname>Waigel</surname><given-names>S</given-names></name>
<name><surname>Vigneswaran</surname><given-names>N</given-names></name>
<name><surname>Zacharias</surname><given-names>W</given-names></name>
</person-group> (<year>2006</year>). <article-title>Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells</article-title>. <source>Toxicol Lett</source> <volume>165</volume>:<fpage>182</fpage>-<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr16-0022034512438402">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Schlesselman</surname><given-names>JJ</given-names></name>
</person-group> (<year>1982</year>). <article-title>Case-control studies: design, conduct, analysis</article-title>. <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>, pp. <fpage>250</fpage>-<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr17-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shariat</surname><given-names>SF</given-names></name>
<name><surname>Ashfaq</surname><given-names>R</given-names></name>
<name><surname>Karakiewicz</surname><given-names>PI</given-names></name>
<name><surname>Saeedi</surname><given-names>O</given-names></name>
<name><surname>Sagalowsky</surname><given-names>AI</given-names></name>
<name><surname>Lotan</surname><given-names>Y</given-names></name>
</person-group> (<year>2007</year>). <article-title>Survivin expression is associated with bladder cancer presence, stage, progression, and mortality</article-title>. <source>Cancer</source> <volume>109</volume>:<fpage>1106</fpage>-<lpage>1113</lpage>.</citation>
</ref>
<ref id="bibr18-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Srivastava</surname><given-names>K</given-names></name>
<name><surname>Srivastava</surname><given-names>A</given-names></name>
<name><surname>Mittal</surname><given-names>B</given-names></name>
</person-group> (<year>2012</year>). <article-title>Survivin promoter −31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>:<fpage>1509</fpage>-<lpage>1516</lpage>.</citation>
</ref>
<ref id="bibr19-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Su</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Xiao</surname><given-names>M</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Yu</surname><given-names>L</given-names></name>
</person-group> (<year>2010</year>). <article-title>Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance</article-title>. <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source> <volume>110</volume>:<fpage>484</fpage>-<lpage>491</lpage>.</citation>
</ref>
<ref id="bibr20-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tang</surname><given-names>DW</given-names></name>
<name><surname>Chang</surname><given-names>KW</given-names></name>
<name><surname>Chi</surname><given-names>CW</given-names></name>
<name><surname>Liu</surname><given-names>TY</given-names></name>
</person-group> (<year>2004</year>). <article-title>Hydroxychavicol modulates benzo[a]pyreneinduced genotoxicity through induction of dihydrodiol dehydrogenase</article-title>. <source>Toxicol Lett</source> <volume>152</volume>:<fpage>235</fpage>-<lpage>243</lpage>.</citation>
</ref>
<ref id="bibr21-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thorgeirsson</surname><given-names>SS</given-names></name>
<name><surname>Grisham</surname><given-names>JW</given-names></name>
</person-group> (<year>2002</year>). <article-title>Molecular pathogenesis of human hepatocellular carcinoma</article-title>. <source>Nat Genet</source> <volume>31</volume>:<fpage>339</fpage>-<lpage>346</lpage>.</citation>
</ref>
<ref id="bibr22-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Upadhyay</surname><given-names>R</given-names></name>
<name><surname>Khurana</surname><given-names>R</given-names></name>
<name><surname>Kumar</surname><given-names>S</given-names></name>
<name><surname>Ghoshal</surname><given-names>UC</given-names></name>
<name><surname>Mittal</surname><given-names>B</given-names></name>
</person-group> (<year>2010</year>). <article-title>Role of survivin gene promoter polymorphism (−31G&gt;C) in susceptibility and survival of esophageal cancer in northern India</article-title>. <source>Ann Surg Oncol</source> <volume>18</volume>:<fpage>880</fpage>-<lpage>887</lpage>.</citation>
</ref>
<ref id="bibr23-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weng</surname><given-names>CJ</given-names></name>
<name><surname>Lin</surname><given-names>CW</given-names></name>
<name><surname>Chung</surname><given-names>TT</given-names></name>
<name><surname>Tsai</surname><given-names>CM</given-names></name>
<name><surname>Chen</surname><given-names>MK</given-names></name>
<name><surname>Yang</surname><given-names>SF</given-names></name>
</person-group> (<year>2011</year>). <article-title>Impact of uPA system gene polymorphisms on the susceptibility of environmental factors to carcinogenesis and the development of clinicopathology of oral cancer</article-title>. <source>Ann Surg Oncol</source> <volume>18</volume>:<fpage>805</fpage>-<lpage>812</lpage>.</citation>
</ref>
<ref id="bibr24-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>HJ</given-names></name>
<name><surname>Chi</surname><given-names>CW</given-names></name>
<name><surname>Liu</surname><given-names>TY</given-names></name>
</person-group> (<year>2005</year>). <article-title>Effects of pH on nicotine-induced DNA damage and oxidative stress</article-title>. <source>J Toxicol Environ Health A</source> <volume>68</volume>:<fpage>1511</fpage>-<lpage>1523</lpage>.</citation>
</ref>
<ref id="bibr25-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Y</given-names></name>
<name><surname>Fang</surname><given-names>F</given-names></name>
<name><surname>Ludewig</surname><given-names>G</given-names></name>
<name><surname>Jones</surname><given-names>G</given-names></name>
<name><surname>Jones</surname><given-names>D</given-names></name>
</person-group> (<year>2004</year>). <article-title>A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells</article-title>. <source>DNA Cell Biol</source> <volume>23</volume>:<fpage>527</fpage>-<lpage>537</lpage>.</citation>
</ref>
<ref id="bibr26-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>L</given-names></name>
<name><surname>Zhu</surname><given-names>H</given-names></name>
<name><surname>Zhou</surname><given-names>B</given-names></name>
<name><surname>Gu</surname><given-names>H</given-names></name>
<name><surname>Yan</surname><given-names>H</given-names></name>
<name><surname>Tang</surname><given-names>N</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population</article-title>. <source>Dig Dis Sci</source> <volume>54</volume>:<fpage>1021</fpage>-<lpage>1028</lpage>.</citation>
</ref>
<ref id="bibr27-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>X</given-names></name>
<name><surname>Xiong</surname><given-names>G</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>K</given-names></name>
<name><surname>Fu</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma</article-title>. <source>J Cancer Res Clin Oncol</source> <volume>135</volume>:<fpage>1341</fpage>-<lpage>1349</lpage>.</citation>
</ref>
<ref id="bibr28-0022034512438402">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yen</surname><given-names>CY</given-names></name>
<name><surname>Liu</surname><given-names>SY</given-names></name>
<name><surname>Chen</surname><given-names>CH</given-names></name>
<name><surname>Tseng</surname><given-names>HF</given-names></name>
<name><surname>Chuang</surname><given-names>LY</given-names></name>
<name><surname>Yang</surname><given-names>CH</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan</article-title>. <source>J Oral Pathol Med</source> <volume>37</volume>:<fpage>271</fpage>-<lpage>277</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>